ERISA Ledger · U.S. DOL EBSA Form 5500 (2023)

Astex Pharmaceuticals, INC.

Official 2023 U.S. DOL Form 5500 summary for Astex Pharmaceuticals, INC. (Astex Pharmaceuticals, INC. 401(k) Profit Sharing Plan · EIN 91-1841574 · PN 003): $42.22M net assets, 117 active participants, and $4.55 per $10,000 (4.55 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAstex Pharmaceuticals, INC.
Filing IdentifierAstex Pharmaceuticals, INC. 401(k) Profit Sharing Plan · EIN 91-1841574 · PN 003
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2023)$42.22M
Active Participants117
Direct Admin Fee Rate$4.55 per $10,000 (4.55 bps)
Cohort Peer Median$18.05 per $10,000 (18.05 bps)
Primary Recordkeeper / ProviderBank of America / Merrill
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI